LENZ Stock Price | LENZ Therapeutics Inc P/E, Revenue, EPS, & Forecasts

LENZ Therapeutics Inc • LENZ

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About LENZ Therapeutics Inc

Ticker

LENZ

Trading on

NASDAQ

ISIN

US52635N1037

Industry

Biotechnology

Sector

Healthcare

CEO

Evert B. Schimmelpennink

Headquarters

201 Lomas Santa Fe Drive, Solana Beach, CA, United States, 92075

Employees

Website

lenz-tx.com

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

Metrics

BasicAdvanced

Market cap

$741M

P/E ratio

EPS

-$2.34

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-59.4M

Ex dividend date

Price & volume

Market cap

$741M

Average daily volume

0.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

3.63

Earnings

EPS

-$2.34

EPS estimate (current quarter)

-$0.40

EPS estimate (next quarter)

-$0.62

EBITDA

$-59.4M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$29.71

52-week Low

$22.52

50-day moving average

$24.61

200-day moving average

$26.10

Short ratio

10.22

Short %

22.12%

Management effectiveness

ROE (TTM)

24.47%

ROA (TTM)

17.75%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

28.1M

Float

11.8M

Insiders %

2.76%

Institutions %

90.78%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 7 analysts.

Average price target

$44.63

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$3.53

-$0.84

320.24%

Q1 • 24Beat

-$0.40

-$0.67

40.30%

Q2 • 24Beat

-$0.38

-$0.43

11.34%

Q3 • 24Beat

-$0.46

-$0.40

15.64%

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-10.2M

∞%

Q3 • 24

$0M

$-12.7M

∞%

Q4 • 24

NaN%

23.86%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$224M

$8.7M

3.90%

Q3 • 24

$215M

$11.2M

5.21%

Q4 • 24

3.89%

28.57%

33.76%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-10.6M

$-62.2M

$29.8M

$-10.8M

Q3 • 24

$-9.1M

$-11.9M

$0.1M

$-9.2M

Q4 • 24

14.20%

80.94%

99.82%

14.30%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a LENZ Therapeutics Inc share?

LENZ Therapeutics Inc shares are currently traded for undefined per share.

How many shares does LENZ Therapeutics Inc have?

LENZ Therapeutics Inc currently has 28.1M shares.

Does LENZ Therapeutics Inc pay dividends?

No, LENZ Therapeutics Inc doesn't pay dividends.

What is LENZ Therapeutics Inc 52 week high?

LENZ Therapeutics Inc 52 week high is $29.71.

What is LENZ Therapeutics Inc 52 week low?

LENZ Therapeutics Inc 52 week low is $22.52.

What is the 200-day moving average of LENZ Therapeutics Inc?

LENZ Therapeutics Inc 200-day moving average is $26.10.

Who is LENZ Therapeutics Inc CEO?

The CEO of LENZ Therapeutics Inc is Evert B. Schimmelpennink.

How many employees LENZ Therapeutics Inc has?

LENZ Therapeutics Inc has 0 employees.

What is the market cap of LENZ Therapeutics Inc?

The market cap of LENZ Therapeutics Inc is $741M.

What is the P/E of LENZ Therapeutics Inc?

The current P/E of LENZ Therapeutics Inc is null.

What is the EPS of LENZ Therapeutics Inc?

The EPS of LENZ Therapeutics Inc is -$2.34.

What is the PEG Ratio of LENZ Therapeutics Inc?

The PEG Ratio of LENZ Therapeutics Inc is null.

What do analysts say about LENZ Therapeutics Inc?

According to the analysts LENZ Therapeutics Inc is considered a buy.